FDA advisers back GSK's OTC nicotine oral spray

23 September 2019 - Deborah Wilkes

Advisers to the US Food and Drug Administration (FDA) have recommended that GlaxoSmithKline (GSK) Consumer Healthcare's nicotine oral spray can be marketed as an OTC product.